-
1
-
-
0026726041
-
-
Simon, R. J.; Kania, R. S.; Zuckermann, R. N.; Huebner, V. D.; Jewell, D. A.; Banville, S.; Ng, S.; Wang, L.; Rosenberg, S.; Marlowe, C. K.; Spellmeyer, D. C.; Tan, R.; Frankel, A. D.; Santi, D. V.; Cohen, F. E.; Bartlett, P. A. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 9367-9371.
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 9367-9371
-
-
Simon, R.J.1
Kania, R.S.2
Zuckermann, R.N.3
Huebner, V.D.4
Jewell, D.A.5
Banville, S.6
Ng, S.7
Wang, L.8
Rosenberg, S.9
Marlowe, C.K.10
Spellmeyer, D.C.11
Tan, R.12
Frankel, A.D.13
Santi, D.V.14
Cohen, F.E.15
Bartlett, P.A.16
-
3
-
-
0036015849
-
-
(b) Burkoth, T. S.; Beausoleil, E.; Kaur, S.; Tang, D.; Cohen, F. E.; Zuckermann, R. N. Chem. Biol. 2002, 9, 647-654.
-
(2002)
Chem. Biol.
, vol.9
, pp. 647-654
-
-
Burkoth, T.S.1
Beausoleil, E.2
Kaur, S.3
Tang, D.4
Cohen, F.E.5
Zuckermann, R.N.6
-
4
-
-
0028033882
-
-
Miller, S. M.; Simon, R. J.; Ng, S.; Zuckermann, R. N.; Kerr, J. M.; Moos, W. H. Bioorg. Med. Chem. Lett. 1994, 4, 2657-2662.
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, pp. 2657-2662
-
-
Miller, S.M.1
Simon, R.J.2
Ng, S.3
Zuckermann, R.N.4
Kerr, J.M.5
Moos, W.H.6
-
5
-
-
0242498356
-
-
Alluri, P. G.; Reddy, M. M.; Bachhawat-Sikder, K.; Olivos, H. J.; Kodadek, T. J. Am. Chem. Soc. 2003, 125, 13995-14004.
-
(2003)
J. Am. Chem. Soc.
, vol.125
, pp. 13995-14004
-
-
Alluri, P.G.1
Reddy, M.M.2
Bachhawat-Sikder, K.3
Olivos, H.J.4
Kodadek, T.5
-
6
-
-
0034700141
-
-
For a recent example, see: Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13003-13008.
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 13003-13008
-
-
Wender, P.A.1
Mitchell, D.J.2
Pattabiraman, K.3
Pelkey, E.T.4
Steinman, L.5
Rothbard, J.B.6
-
7
-
-
27744455370
-
-
Nielsen, P. E., Ed.; Wiley-VCH: Weinheim, Germany
-
Patch, J. A.; Kirshenbaum, K.; Seurynck, S. L.; Zuckermann, R. N.; Barron, A. E. In Pseudopeptides in Drug Development; Nielsen, P. E., Ed.; Wiley-VCH: Weinheim, Germany, 2004.
-
(2004)
Pseudopeptides in Drug Development
-
-
Patch, J.A.1
Kirshenbaum, K.2
Seurynck, S.L.3
Zuckermann, R.N.4
Barron, A.E.5
-
8
-
-
0032515982
-
-
(a) Kirshenbaum, K.; Barron, A. E.; Goldsmith, R. A.; Armand, P.; Bradley, E. K.; Truong, K. T. V.; Dill, K. A.; Cohen, F. E.; Zuckermann, R. N. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4303-4308.
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 4303-4308
-
-
Kirshenbaum, K.1
Barron, A.E.2
Goldsmith, R.A.3
Armand, P.4
Bradley, E.K.5
Truong, K.T.V.6
Dill, K.A.7
Cohen, F.E.8
Zuckermann, R.N.9
-
9
-
-
0034822676
-
-
(b) Wu, C. W.; Sanborn, T. J.; Zuckermann, R. N.; Barron, A. E. J. Am. Chem. Soc. 2001, 123, 2958-2963.
-
(2001)
J. Am. Chem. Soc.
, vol.123
, pp. 2958-2963
-
-
Wu, C.W.1
Sanborn, T.J.2
Zuckermann, R.N.3
Barron, A.E.4
-
10
-
-
0242417008
-
-
For recent commentaries on the role of aromatic interactions in biological systems, see: (a) Meyer, E. A.; Castellano, R. K.; Diederich, F. Angew. Chem., Int. Ed. 2003, 42, 1210-1250. (b) Waters, M. L. Curr. Opin. Chem. Biol. 2002, 6, 736-741.
-
(2003)
Angew. Chem., Int. Ed.
, vol.42
, pp. 1210-1250
-
-
Meyer, E.A.1
Castellano, R.K.2
Diederich, F.3
-
11
-
-
0036897848
-
-
For recent commentaries on the role of aromatic interactions in biological systems, see: (a) Meyer, E. A.; Castellano, R. K.; Diederich, F. Angew. Chem., Int. Ed. 2003, 42, 1210-1250. (b) Waters, M. L. Curr. Opin. Chem. Biol. 2002, 6, 736-741.
-
(2002)
Curr. Opin. Chem. Biol.
, vol.6
, pp. 736-741
-
-
Waters, M.L.1
-
12
-
-
0000908874
-
-
Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H. J. Am. Chem. Soc. 1992, 114, 10646-10647.
-
(1992)
J. Am. Chem. Soc.
, vol.114
, pp. 10646-10647
-
-
Zuckermann, R.N.1
Kerr, J.M.2
Kent, S.B.H.3
Moos, W.H.4
-
15
-
-
3042708379
-
-
(b) Bowman, M. D.; Jeske, R. C.; Blackwell, H. E. Org. Lett. 2004, 6, 2019-2022.
-
(2004)
Org. Lett.
, vol.6
, pp. 2019-2022
-
-
Bowman, M.D.1
Jeske, R.C.2
Blackwell, H.E.3
-
17
-
-
0037078825
-
-
(a) Olivos, H. J.; Alluri, P. G.; Reddy, M. M.; Salony, D.; Kodadek, T. Org. Lett. 2002, 4, 4057-4059.
-
(2002)
Org. Lett.
, vol.4
, pp. 4057-4059
-
-
Olivos, H.J.1
Alluri, P.G.2
Reddy, M.M.3
Salony, D.4
Kodadek, T.5
-
18
-
-
17844371428
-
-
note
-
Commercial MW reactors allow for real-time temperature monitoring and variable power control during chemical reactions.
-
-
-
-
19
-
-
17844364063
-
-
note
-
All MW-assisted reactions were performed in a Milestone Ethos Microsynth multimodal microwave reactor.
-
-
-
-
20
-
-
17844383075
-
-
note
-
See the Supporting Information for full details of room-temperature and MW-assisted synthesis, characterization, and purification methods.
-
-
-
-
21
-
-
17844374979
-
-
note
-
The major impurities observed in peptoid syntheses were either terminal bromides or oligomers with one or more monomer deletions (as determined by LC-MS analyses).
-
-
-
-
22
-
-
0242299241
-
-
Wu, C. W.; Kirshenbaum, K.; Sanborn, T. J.; Patch, J. A.; Huang, K.; Dill, K. A.; Zuckermann, R. N.; Barron, A. E. J. Am. Chem. Soc. 2003, 125, 13525-13530.
-
(2003)
J. Am. Chem. Soc.
, vol.125
, pp. 13525-13530
-
-
Wu, C.W.1
Kirshenbaum, K.2
Sanborn, T.J.3
Patch, J.A.4
Huang, K.5
Dill, K.A.6
Zuckermann, R.N.7
Barron, A.E.8
-
23
-
-
17844385166
-
-
note
-
A report of our syntheses of (±)-1-(pentafluorophenyl)ethylamine (fpe, 9) and (S)-1-(pentafluorophenyl)ethylamine is forthcoming.
-
-
-
-
24
-
-
17844382252
-
-
note
-
5 peptoids in order to conserve this valuable amine. We found that 10 couplings could be performed by recycling the same 2 mL of 1 M amine solution before product purity was affected (by >5%).
-
-
-
-
25
-
-
17844411572
-
-
note
-
Aniline was incorporated into peptoids more efficiently using the MW method relative to the 25°C control, albeit with reduced purities overall (30% vs 11% for a homopentamer); see the Supporting Information.
-
-
-
-
26
-
-
17844391373
-
-
note
-
The heating profile of a compound under MW irradiation is directly dependent on its dielectric constant. See ref 11a,c.
-
-
-
-
27
-
-
17844406742
-
-
note
-
These control studies are complicated by our inability to attain the rapid heating profile achieved in the MW reactor for the amination step (25-95°C in 90 s) using conventional heating methods (e.g., in an oil or sand bath).
-
-
-
-
28
-
-
17844367943
-
-
note
-
9 22 was synthesized using the MW-assisted method described herein. Peptoids were purified to ≥95% homogeneity by reverse-phase HPLC prior to CD analysis. (24) Peptoid 21 could also experience electrostatically destabilizing side-chain interactions in a helical conformation (Figure 2b).
-
-
-
|